Announcements
18 July 2025
Cancers | Highly Cited Special Issues in 2024 in the “Cancer Immunology and Immunotherapy” Section
We are delighted to share some highly cited Special Issues in 2024 from the “Cancer Immunology and Immunotherapy” Section of Cancers (ISSN: 2072-6694).
The list of highly cited Special Issues can be viewed below:
“Inflammation, Immunity, and Cancer Progression”
Guest Editors: Dr. Deepak Parashar, Dr. Vivek K. Kashyap and Dr. Subhash Tripathi
Submission deadline: 31 May 2024
“PD-1/PD-L1 Immune Checkpoint Therapy: From Predictive Biomarkers to Noninvasive Imaging”
Guest Editors: Prof. Dr. Patrizia Ferroni, Prof. Dr. Fiorella Guadagni and Prof. Dr. Mario Roselli
Submission deadline: 25 April 2024
“Role of Immune Checkpoint Inhibitors or Targeted Therapy in the Treatment of Patients with Melanoma Volume II”
Guest Editors: Dr. Henrik Schmidt and Dr. Eva Ellebæk
Submission deadline: 20 September 2024
“Near-Infrared Photoimmunotherapy for Cancer Treatment”
Guest Editor: Dr. Hisataka Kobayashi
Submission deadline: 10 April 2024
“Macrophage-Directed Cancer Immunotherapy”
Guest Editor: Dr. Zahra Payandeh
Submission deadline: 31 December 2024
“State-of-the-Art Cancer Immunology and Immunotherapy in the USA”
Guest Editors: Prof. Dr. Razelle Kurzrock, Dr. Anwaar Saeed, Dr. Linlin Guo and Dr. Ludimila Cavalcante
Submission deadline: 20 June 2024
We invite you to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
